News | August 04, 2022
Lupin Q1 FY23 consolidated loss drops to Rs. 89.08 Cr
Lupin is the 6th largest company in the Indian Pharmaceutical Market
Lupin is the 6th largest company in the Indian Pharmaceutical Market
Biopharma and CROs to benefit from simplified access to global research sites
India imported medical devices worth Rs. 63,200 crore in 2021-22, up 41% from Rs. 44,708 crore in 2020-21
Fermentation-based manufacturing leverages Evonik’s biotechnology platform
VACUUBRAND has evolved rapidly in recent years, developing new innovative vacuum technology for laboratories, research and engineering
A newly revealed mechanism by Weizmann Institute of Science of ketamine’s action on potassium channels in neurons may lead to improved therapies for depression
Safety in these pediatric populations was consistent with the known safety profile across approved adult and pediatric indications1,2
The Congress was held on June, 20-21, 2022 in Berlin, Germany
Tabrecta is the number one prescribed targeted therapy for advanced NSCLC with alterations leading to METex14 skipping globally
This is the first Agilent lab to receive the My Green Lab Certification and plans are under way to certify additional labs.
Subscribe To Our Newsletter & Stay Updated
